Cargando…
Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment
Genetically engineered T and NK cells expressing a chimeric antigen receptor (CAR) are promising cytotoxic cells for the treatment of hematological malignancies and solid tumors. Despite the successful therapies using CAR-T cells, they have some disadvantages, such as cytokine release syndrome (CRS)...
Autores principales: | Sadowski, Karol, Olejarz, Wioletta, Basak, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739283/ https://www.ncbi.nlm.nih.gov/pubmed/36499331 http://dx.doi.org/10.3390/ijms232315006 |
Ejemplares similares
-
Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives
por: Popa, Irene Paula, et al.
Publicado: (2022) -
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021) -
Next generations of CAR-T cells - new therapeutic opportunities in hematology?
por: Tomasik, Jaromir, et al.
Publicado: (2022) -
Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma
por: Jasiński, Marcin, et al.
Publicado: (2021)